AbbVie has been somewhat immune to the crisis with its shares rising 2.27% to $104.50 at 11:10 EST on Tuesday, after three sequential sessions in a row of gains. The New York Stock Exchange is rising 1.39% to $14,192.20, following yesterday’s upward trend, on what as yet seems, an all-around positive trend exchanging session today.
AbbVie’s last close was $102.18, under its 52-week high of $104.12.
AbbVie’s sales growth is 57.6% for the present quarter and 48.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 29.4% and 16.1%, respectively.
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.
AbbVie’s stock is valued at $104.50 at 11:10 EST, above its 52-week high of $104.12.
AbbVie’s worth is way higher than its 50-day moving average of $90.21 and way above its 200-day moving average of $92.72.